E88.9
Conditions
Interventions
Group 1: Daily consumption of 200 mL milk, enriched with 2 g of phospholipids, for eight weeks.
Group 2: Daily consumption of 200 mL milk, enriched with 2 g of triacyglycerols, for eight weeks.
Sponsors
Max Rubner-Institut Bundesforschungsinstitut für Ernährung und Lebnsmittel
Forschungskreis der Ernährungsindustrie e.V. (FEI)
Eligibility
Sex/Gender
Male
Age
50 Years to 75 Years
Inclusion criteria
Inclusion criteria: Male gender, overweight Between 50 and 75 years of age Non-smoker Subjects who gave written consent to participate in this study
Exclusion criteria
Exclusion criteria: Subjects with fasting glucose above 120 mg/dl Subjects suffering from a disease regarding the resorption of nutrients, digestive function, metabolism, or excretion Subjects with a known milk protein allergy Subjects taking nutritional supplements during the trial period which can influence study parameters Subjects taking medications which can influence study parameters Subjects that underwent surgery of the gastrointestinal tract or a corticoid treatment within the past three months Subjects with an above average consumption of milk and milk products Subjects experiencing unjustifiable adverse events Subjects experiencing acute gastrointestinal disease during the trial period Subjects who do not act compliantly Subjects who withdraw their consent to participate in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum total- and HDL cholesterol ratio at the end of intervention (after 8 weeks) | — |
Secondary
| Measure | Time frame |
|---|---|
| Risk factors for the metabolic syndrome at the end of intervention (after 8 weeks): waist circumference, fasting blood triacylglycerol and glucose, blood pressure | — |
Countries
Germany
Contacts
Public ContactAnne Weiland
Max Rubner-Institut Bundesforschungsinstitut für Ernährung und Lebnsmittel
Outcome results
None listed